Mary Kay Fenton

CGEM

Mary Kay Fenton serves as Chief Financial Officer at Cullinan Therapeutics, Inc. (CGEM). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$59.9K

Net Position

Net Seller

$59.9K

Companies Traded

CGEM

Active Period

Feb 2026

1 total trades

Most Recent

Sell CGEM

Feb 20, 2026 · $59.9K

Mary Kay Fenton's Insider Trading at Cullinan Therapeutics, Inc. (CGEM)

Buys

0 · $0.00

Sells

1 · $59.9K

Total Shares Bought

Total Shares Sold

4,398

CGEM Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 20, 2026	Sell	4,398	$13.62	$59.9K	0

Related Insiders

Jennifer Michaelson

officer: Chief Scientific Officer

CGEMSell · Mar 9, 2026

AHMED NADIM

President and CEO

CGEMSell · Feb 25, 2026

Jeffrey Alan Jones

officer: Chief Medical Officer

CGEMSell · Feb 25, 2026

SUMER JACQUELYN L

officer: Chief Legal Officer

CGEMSell · Feb 25, 2026

Explore More Insider Trading Data

CGEM Insider Trading Activity

View all insider trades at Cullinan Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity